In agreement with this, ROS overproduction renders pancreatic adenocarcinoma cells susceptible to cell death [70], and the progression of pancreatic adenocarcinoma often coincides with mutations inactivating Keap-1 and rendering NRF2 constitutively active [71]. The gene discussed is NFE2L2; the disease is pancreatic adenocarcinoma.